Title: Polypharmacy and Pattern of medication use among patients with gastroesophageal reflux
disease: results from Pars Cohort study
Version: 1 Date: 14 Aug 2023
Reviewer's report:
- For world standard population, It is recommended to mention (an) appropriate reference(s).
- In third line in results, please add unit (likely, years).
- In table 1:
1. The lines of table should be revised
2. Symbol ">=" replace with "#" etc.
3. Sum of cells (total) are not same, including tobacco use
- In table 2:
Please add comparing group(s) and their measures in table
- It is better to show percentages with uniform decimals (throughout the manuscript)
Title: Polypharmacy and Pattern of medication use among patients with gastroesophageal reflux
disease: results from Pars Cohort study
Version: 1 Date: 14 Aug 2023
Reviewer's report:
- For world standard population, It is recommended to mention (an) appropriate reference(s).
- In third line in results, please add unit (likely, years).
- In table 1:
1. The lines of table should be revised
2. Symbol ">=" replace with "#" etc.
3. Sum of cells (total) are not same, including tobacco use
- In table 2:
Please add comparing group(s) and their measures in table
- It is better to show percentages with uniform decimals (throughout the manuscript)
Please review this paper.
user
Title: Polypharmacy and Pattern of medication use among patients with gastroesophageal reflux
disease: results from Pars Cohort study
Version: 1 Date: 14 Aug 2023
Reviewer's report:
- For world standard population, It is recommended to mention (an) appropriate reference(s).
- In third line in results, please add unit (likely, years).
- In table 1:
1. The lines of table should be revised
2. Symbol ">=" replace with "#" etc.
3. Sum of cells (total) are not same, including tobacco use
- In table 2:
Please add comparing group(s) and their measures in table
- It is better to show percentages with uniform decimals (throughout the manuscript)
assistant